LSE:AZNPharmaceuticals
Assessing AstraZeneca’s (LSE:AZN) Valuation After Its Recent Share Price Cool‑Off
What is happening with AstraZeneca shares?
AstraZeneca (LSE:AZN) has quietly cooled off after a strong run this year, with the share price slipping around 1% over the past month, even though the past 3 months remain firmly positive.
See our latest analysis for AstraZeneca.
That dip comes after a powerful run, with a roughly 21% 3 month share price return and a double digit year to date gain, while a 33.6% one year total shareholder return signals momentum is still broadly intact.
If...